Marco Ruella, MD @MarcoRuella @UofPenn #ASH21 #GutMicrobiot #Cancer #Research Abstracts 163 And 253 Microbiota

Marco Ruella, MD, Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies and Scientific Director of the Lymphoma Program at the Hospital of the University of Pennsylvania speaks about the ASH 2021 Abstract 163 Gut Microbiota Tuning Promotes Tumor-Associated Antigen Cross Presentation and Enhances CAR T Antitumor Effects and 253 The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies.

Link to Abstract 163:
https://ash.confex.com/ash/2021/webprogram/Paper151093.html

Link to Clinical Trial:
https://clinicaltrials.gov/ct2/show/NCT02030847

Link to Abstract 253:
https://ash.confex.com/ash/2021/webprogram/Paper153945.html